Similar articles

• Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.

  Halsey NA, Coberly JS, Desormeaux J, Losikoff P, Atkinson J, Moulton LH, Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R, Chaisson RE. Halsey NA, et al. Lancet. 1998 Mar 14;351(9105):786-92. doi: 10.1016/S0140-6736(97)06532-X. Lancet. 1998. PMID: 9519950 Clinical Trial.
• Prevention of tuberculosis in HIV-1.

  Halsey NA, Coberly J, Chaisson R. Halsey NA, et al. Lancet. 1998 Aug 29;352(9129):742. doi: 10.1016/S0140-6736(05)60866-5. Lancet. 1998. PMID: 9729026 No abstract available.
• Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.

  Gordin F, Chaisson RE, Matts JP, Miller C, de Lourdes Garcia M, Hafner R, Valdespino JL, Coberly J, Schechter M, Klukowicz AJ, Barry MA, O'Brien RJ. Gordin F, et al. JAMA. 2000 Mar 15;283(11):1445-50. doi: 10.1001/jama.283.11.1445. JAMA. 2000. PMID: 10732934 Clinical Trial.
• Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.

  Apers L, Lynen L, Worodria W, Colebunders R. Apers L, et al. Trop Med Int Health. 2005 Dec;10(12):1209-14. doi: 10.1111/j.1365-3156.2005.01516.x. Trop Med Int Health. 2005. PMID: 16359399 Review.
• Tuberculosis preventive therapy for HIV-infected persons in less developed countries.

  Kritski AL. Kritski AL. Int J Tuberc Lung Dis. 2000 Feb;4(2 Suppl 1):S76-81. Int J Tuberc Lung Dis. 2000. PMID: 10688154 Review. No abstract available.